Horizon Investments’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11K Buy
72
+56
+350% +$8.58K ﹤0.01% 1198
2025
Q4
$2.21K Sell
16
-18
-53% -$2.36K ﹤0.01% 1205
2025
Q3
$4.36K Buy
+34
New +$4.15K ﹤0.01% 1069
2025
Q2
Sell
-32
Closed -$3.57K 1129
2025
Q1
$3.57K Sell
32
-5
-14% -$532 ﹤0.01% 691
2024
Q4
$3.6K Sell
37
-1
-3% -$107 ﹤0.01% 693
2024
Q3
$4.37K Sell
38
-6
-14% -$681 ﹤0.01% 666
2024
Q2
$4.68K Buy
44
+4
+10% +$402 ﹤0.01% 673
2024
Q1
$3.87K Buy
40
+21
+111% +$2.15K ﹤0.01% 656
2023
Q4
$1.92K Buy
+19
New +$1.83K ﹤0.01% 650
2020
Q3
Sell
-66,138
Closed -$5.78M 437
2020
Q2
$5.78M Buy
66,138
+20,785
+46% +$1.79M 0.14% 76
2020
Q1
$3.74M Buy
+45,353
New +$4.05M 0.18% 43
2018
Q4
Sell
-22,965
Closed -$1.77M 276
2018
Q3
$1.77M Buy
22,965
+11,756
+105% +$869K 0.06% 99
2018
Q2
$759K Sell
11,209
-25
-0.2% -$1.73K 0.03% 158
2018
Q1
$814K Sell
11,234
-6,488
-37% -$494K 0.04% 129
2017
Q4
$1.28M Buy
17,722
+516
+3% +$38.9K 0.08% 84
2017
Q3
$1.24M Buy
17,206
+6,868
+66% +$519K 0.07% 75
2017
Q2
$745K Buy
+10,338
New +$733K 0.04% 92

Other funds holding NVS

Horizon Investments's NVS Position: Q1 2026 in Review

Horizon Investments increased its Novartis (NVS) stake by 350% in Q1 2026, buying an estimated $8.58K and bringing the position to 72 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #1198.

Horizon Investments first reported a position in NVS in Q2 2017 and has held it in 17 quarters since. The position peaked at $5.78M in Q2 2020. 1,596 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Horizon Investments held 72 shares of Novartis worth $11K as of Q1 2026.
  • Horizon Investments bought 56 Novartis shares in Q1 2026, an estimated $8.58K.
  • Novartis made up ﹤0.01% of Horizon Investments's portfolio in Q1 2026, its #1198 holding.
  • Horizon Investments first reported a position in Novartis in Q2 2017 and has held it in 17 quarters since.
  • Horizon Investments's Novartis position peaked at $5.78M in Q2 2020.
  • 1,596 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.